IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 94

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: “COVID 19 IMPACT ON PHARMACEUTICAL STOCK ”
Authors Name: Bhalani Nicky , Nancy Bachani , Dr.Aashaka Thakkar
Download E-Certificate: Download
Author Reg. ID:
IJNRD_187893
Published Paper Id: IJNRD2303084
Published In: Volume 8 Issue 3, March-2023
DOI:
Abstract: In light of the recent Covid 19 epidemic, this research will analyze the performance of top pharmaceutical companies trading on India's National Stock Exchange. We have picked 10 major pharmaceutical businesses registered with NSE, and the decision was completely based on the market capitalization of the companies. The study's overarching hypothesis was that pharmaceutical equities will go in the opposite direction of the market (contrarian effect). The time frame that was examined was split into two parts: before and after the Covid 19 crisis. There are a total of 123 daily price observations for the 10 pharmaceutical firms included in this study. The duration of research is extending from 3rd September 2019 to 28th February 2020. According to the data, the momentum effect is still at work in the pharmaceutical stock market, with pharmaceutical equities tracking the general benchmarking index's movements. The total number of companies is reduced.
Keywords: COVID 19,Pharmacutical industry, PHARMACUTICAL MARKET and international trade
Cite Article: "“COVID 19 IMPACT ON PHARMACEUTICAL STOCK ”", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 3, page no.a804-a813, March-2023, Available :http://www.ijnrd.org/papers/IJNRD2303084.pdf
Downloads: 000118748
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2303084
Registration ID: 187893
Published In: Volume 8 Issue 3, March-2023
DOI (Digital Object Identifier):
Page No: a804-a813
Country: Vadodara, GUJARAT, India
Research Area: Management
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2303084
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2303084
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD